\-\ Texto\\:\\ \ \(0\)\
\-\ wbc\\ \\-\\ 3\\.6\\ \\/\\ 69\\%\\ pmns\\,\\ 5\\%\\ lymphocytes\\,\\ 3\\%\\ reactive\\ lymphocytes\\,\\ 14\\%\\ monocytes\\,\\ 8\\%\\ eosinophils\\.\ \(0\)\
\-\ diffuse\\ thickening\\ and\\ enhancement\\ of\\ soft\\ tissues\\ predominantly\\ of\\ dorsum\\ or\\ right\\ hand\\ with\\ focal\\ soft\\ tissue\\ enlargement\\ \\(tumoral\\)\\ of\\ third\\ digit\\.\ \(0\)\
\-\ mycosis\\ fungoides\ \(3\)\
\-\ soft\\ tissue\\ sarcoma\ \(13\)\
\-\ giant\\ cell\\ tumor\\ of\\ tendon\\ sheath\ \(1\)\
\-\ xanthoma\ \(12\)\
\-\ lymphoma\ \(373\)\
\-\ 34\\ year\\ old\\ african\\-american\\ female\\ with\\ nine\\-year\\ history\\ of\\ gradually\\ progressive\\ cutaneous\\ lesions\\ that\\ now\\ cover\\ entire\\ body\\.\\ \\ there\\ is\\ erythroderma\\ of\\ the\\ right\\ hand\\ and\\ extensive\\ focal\\ enlargement\\ of\\ the\\ right\\ third\\ finger\\.\ \(0\)\
\-\ see\\ factoid\ \(116\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lymphocytes\\:\\ 0\\.2846497812832291\ \(0\)\
\-\ erythroderma\\:\\ 0\\.20241137980985144\ \(0\)\
\-\ soft\\:\\ 0\\.20214792135682905\ \(0\)\
\-\ hand\\:\\ 0\\.19787705196550331\ \(0\)\
\-\ enlargement\\:\\ 0\\.19406817897017772\ \(0\)\
\-\ third\\:\\ 0\\.19274341789580546\ \(0\)\
\-\ fungoides\\:\\ 0\\.18703176072459315\ \(0\)\
\-\ mycosis\\:\\ 0\\.18208062925238266\ \(0\)\
\-\ monocytes\\:\\ 0\\.17803526028434166\ \(0\)\
\-\ xanthoma\\:\\ 0\\.1746149495567388\ \(0\)\
\-\ of\\:\\ 0\\.17338294697699708\ \(0\)\
\-\ pmns\\:\\ 0\\.16903875984409014\ \(0\)\
\-\ cover\\:\\ 0\\.16670101016712435\ \(0\)\
\-\ tumoral\\:\\ 0\\.15923533047148053\ \(0\)\
\-\ eosinophils\\:\\ 0\\.1562725225540766\ \(0\)\
\-\ focal\\:\\ 0\\.15141570609769026\ \(0\)\
\-\ dorsum\\:\\ 0\\.148220339102387\ \(0\)\
\-\ digit\\:\\ 0\\.13890457991401173\ \(0\)\
\-\ 69\\:\\ 0\\.1328407200171287\ \(0\)\
\-\ tissue\\:\\ 0\\.1327904856418581\ \(0\)\
\-\ gradually\\:\\ 0\\.13189640302856678\ \(0\)\
\-\ cutaneous\\:\\ 0\\.1314389002183679\ \(0\)\
\-\ right\\:\\ 0\\.1258885778726502\ \(0\)\
\-\ sheath\\:\\ 0\\.1258627105057192\ \(0\)\
\-\ finger\\:\\ 0\\.12028652079307055\ \(0\)\
\-\ entire\\:\\ 0\\.11517163876076386\ \(0\)\
\-\ giant\\:\\ 0\\.11289924435987204\ \(0\)\
\-\ predominantly\\:\\ 0\\.11083810859725098\ \(0\)\
\-\ tendon\\:\\ 0\\.11048309142046094\ \(0\)\
\-\ 34\\:\\ 0\\.11030769050557618\ \(0\)\
\-\ reactive\\:\\ 0\\.10862596920423438\ \(0\)\
\-\ sarcoma\\:\\ 0\\.10617513832051234\ \(0\)\
\-\ tissues\\:\\ 0\\.09979201967550556\ \(0\)\
\-\ extensive\\:\\ 0\\.09751962527461375\ \(0\)\
\-\ progressive\\:\\ 0\\.09693824441084882\ \(0\)\
\-\ 14\\:\\ 0\\.09449554115094878\ \(0\)\
\-\ wbc\\:\\ 0\\.08945890629668499\ \(0\)\
\-\ factoid\\:\\ 0\\.0883926062216274\ \(0\)\
\-\ now\\:\\ 0\\.08688348533223106\ \(0\)\
\-\ thickening\\:\\ 0\\.08610697189495113\ \(0\)\
\-\ body\\:\\ 0\\.08329878551048923\ \(0\)\
\-\ diffuse\\:\\ 0\\.07937442712778513\ \(0\)\
\-\ see\\:\\ 0\\.07873372524418976\ \(0\)\
\-\ year\\:\\ 0\\.07801214567987559\ \(0\)\
\-\ lymphoma\\:\\ 0\\.07537967467225912\ \(0\)\
\-\ enhancement\\:\\ 0\\.07285091117695511\ \(0\)\
\-\ lesions\\:\\ 0\\.07269001054303137\ \(0\)\
\-\ cell\\:\\ 0\\.07240329743416822\ \(0\)\
\-\ tumor\\:\\ 0\\.0662029287226335\ \(0\)\
\-\ female\\:\\ 0\\.061075378633924995\ \(0\)\
\-\ that\\:\\ 0\\.05492619801594362\ \(0\)\
\-\ and\\:\\ 0\\.05230786716241372\ \(0\)\
\-\ the\\:\\ 0\\.05051020203874196\ \(0\)\
\-\ there\\:\\ 0\\.05036141096778897\ \(0\)\
\-\ with\\:\\ 0\\.04956758378471456\ \(0\)\
\-\ history\\:\\ 0\\.04835668389517392\ \(0\)\
\-\ or\\:\\ 0\\.04403110020217607\ \(0\)\
\-\ old\\:\\ 0\\.037459332213534355\ \(0\)\
\-\ is\\:\\ 0\\.03466177964594949\ \(0\)\
